title: Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997.
authors.forename: R A
authors.initials: RA
authors.lastname: Rudick
authors.forename: D E
authors.initials: DE
authors.lastname: Goodkin
authors.forename: L D
authors.initials: LD
authors.lastname: Jacobs
authors.forename: D L
authors.initials: DL
authors.lastname: Cookfair
authors.forename: R M
authors.initials: RM
authors.lastname: Herndon
authors.forename: J R
authors.initials: JR
authors.lastname: Richert
authors.forename: A M
authors.initials: AM
authors.lastname: Salazar
authors.forename: J S
authors.initials: JS
authors.lastname: Fischer
authors.forename: C V
authors.initials: CV
authors.lastname: Granger
authors.forename: J H
authors.initials: JH
authors.lastname: Simon
authors.forename: J J
authors.initials: JJ
authors.lastname: Alam
authors.forename: N A
authors.initials: NA
authors.lastname: Simonian
authors.forename: M K
authors.initials: MK
authors.lastname: Campion
authors.forename: D M
authors.initials: DM
authors.lastname: Bartoszak
authors.forename: D N
authors.initials: DN
authors.lastname: Bourdette
authors.forename: J
authors.initials: J
authors.lastname: Braiman
authors.forename: C M
authors.initials: CM
authors.lastname: Brownscheidle
authors.forename: M E
authors.initials: ME
authors.lastname: Coats
authors.forename: S L
authors.initials: SL
authors.lastname: Cohan
authors.forename: D S
authors.initials: DS
authors.lastname: Dougherty
authors.forename: R P
authors.initials: RP
authors.lastname: Kinkel
authors.forename: M K
authors.initials: MK
authors.lastname: Mass
authors.forename: F E
authors.initials: FE
authors.lastname: Munschauer
authors.forename: R L
authors.initials: RL
authors.lastname: Priore
authors.forename: P M
authors.initials: PM
authors.lastname: Pullicino
authors.forename: B J
authors.initials: BJ
authors.lastname: Scherokman
authors.forename: B
authors.initials: B
authors.lastname: Weistock-Guttman
authors.forename: R H
authors.initials: RH
authors.lastname: Whitham
mesh_terms: D017326:Clinical Trials, Phase III as Topic / Q000266:history; D004185:Disability Evaluation; D005260:Female; D049673:History, 20th Century; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000266:history* / Q000627:therapeutic use; D008297:Male; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000266:history*; D016032:Randomized Controlled Trials as Topic / Q000266:history
chemical_list: D016899:Interferon-beta; D000068556:Interferon beta-1a